-
1 Comment
Nanollose Limited is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Nanollose Limited's total revenue sank by 66.9% to $2K since the same quarter in the previous year.
Its net income has increased by 25.0% to $-441K since the same quarter in the previous year.
Finally, its free cash flow fell by 28.6% to $-347K since the same quarter in the previous year.
Based on the above factors, Nanollose Limited gets an overall score of 2/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU000000NC68 |
Sector | Consumer Cyclical |
Industry | Textile Manufacturing |
Market Cap | 9M |
---|---|
Beta | 0.1 |
Target Price | None |
PE Ratio | None |
Dividend Yield | None |
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre for use in textiles; Jelli Grow, an alternative seed germination and plant growing material; and Nufolium that is used for nonwoven applications, such as wipes. It also offers Biollose, a soilless growing media; and MicroGel, which is developed specifically for the commercial microgreens market. Nanollose Limited The company was incorporated in 2014 and is based in Nedlands, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NC6.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025